Atlas Trials

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

Clinical trial NCT02983708 · COMPLETED

Trial details

NCT number
NCT02983708
Sponsor
Hanyang University Seoul Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
NeurodegenerationG-CSFPeripheral Blood Mononuclear CellsCerebral Palsy
Start date
2011-08-01
Primary completion
2014-09-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.